Assignee
PROVECTUS PHARMATECH INC
US·17 granted patents·12 pending applications·78 citations·filing 1999–2025
Top patents by PatentIndex Score
29 records- 0189US7390668B2Intracorporeal medicaments for photodynamic treatment of diseasePROVECTUS PHARMATECH INC·Filed 2001·Granted Jun 24, 2008·22 cites·23 claims
- 0288US10471144B2Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancerPROVECTUS PHARMATECH INC·Filed 2017·Granted Nov 12, 2019·5 cites·26 claims
- 0388US7648695B2Medicaments for chemotherapeutic treatment of diseasePROVECTUS PHARMATECH INC·Filed 2001·Granted Jan 19, 2010·24 cites·4 claims
- 0487US11071781B2Combination of local and systemic immunomodulative therapies for enhanced treatment of cancerPROVECTUS PHARMATECH INC·Filed 2019·Granted Jul 27, 2021·1 cites·33 claims
- 0584US7427389B2Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenesPROVECTUS PHARMATECH INC·Filed 2005·Granted Sep 23, 2008·2 cites·6 claims
- 0684US7402299B2Intracorporeal medicaments for photodynamic treatment of diseasePROVECTUS PHARMATECH INC·Filed 2004·Granted Jul 22, 2008·12 cites·2 claims
- 0783US7338652B2Methods for positron emission imaging with radiolabeled halogenated xanthenes diagnostic agentsPROVECTUS PHARMATECH INC·Filed 2005·Granted Mar 4, 2008·2 cites·4 claims
- 0881US12377068B2In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumorsPROVECTUS PHARMATECH INC·Filed 2024·Granted Aug 5, 2025·0 cites·6 claims
- 0981US11058664B2In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumorsPROVECTUS PHARMATECH INC·Filed 2019·Granted Jul 13, 2021·1 cites·13 claims
- 1077US7863047B2Intracorporeal medicaments for photodynamic treatment of diseasePROVECTUS PHARMATECH INC·Filed 2008·Granted Jan 4, 2011·1 cites·2 claims
- 1177US2022008534A1Combination Of Local And Systemic Immunomodulative Therapies For Enhanced Treatment of CancerPROVECTUS PHARMATECH INC·Filed 2021·Application pending·0 cites
- 1271US12133840B2Halogenated xanthene composition and method for treating hematologic cancersPROVECTUS PHARMATECH INC·Filed 2022·Granted Nov 5, 2024·0 cites·15 claims
- 1370US11974980B2In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumorsPROVECTUS PHARMATECH INC·Filed 2021·Granted May 7, 2024·0 cites·9 claims
- 1470US2008311035A1Diagnostic Agents For Positron Emission Imaging Using Radiolabeled Halogenated XanthenesPROVECTUS PHARMATECH INC·Filed 2008·Application pending·0 cites
- 1569US2024316191A1Halogenated Xanthenes as Vaccine AdjuvantsPROVECTUS PHARMATECH INC·Filed 2024·Application pending·0 cites
- 1667US11419844B2Halogenated xanthene composition and method for treating hematologic cancersPROVECTUS PHARMATECH INC·Filed 2019·Granted Aug 23, 2022·0 cites·17 claims
- 1765US11938182B2Halogenated xanthenes as vaccine adjuvantsPROVECTUS PHARMATECH INC·Filed 2021·Granted Mar 26, 2024·0 cites·9 claims
- 1864US2023233515A1Photodynamic anti-gram-positive bacterial activity of pharmaceutical-grade rose bengalPROVECTUS PHARMATECH INC·Filed 2022·Application pending·0 cites
- 1963US11975106B2Uses of halogenated xanthenes in oncology and virologyPROVECTUS PHARMATECH INC·Filed 2021·Granted May 7, 2024·0 cites·25 claims
- 2062US2023270657A1Halogenated Xanthene-Containing Topical Anti-Gram-Positive Bacterial Ophthalmic Composition and MethodPROVECTUS PHARMATECH INC·Filed 2022·Application pending·0 cites
- 2160US2021299055A1Treatment of Solid Cancerous Tumors by Oral Administration of a Halogenated XanthenePROVECTUS PHARMATECH INC·Filed 2021·Application pending·0 cites
- 2257US2026069565A1Method of Treating Amyotrophic Lateral SclerosisPROVECTUS PHARMATECH INC·Filed 2025·Application pending·0 cites
- 2357US2011097280A1Intracorporeal Medicaments for Photodynamic Treatment of DiseasePROVECTUS PHARMATECH INC·Filed 2010·Application pending·0 cites
- 2457US2024325341A1Anti-bacterial effect of halogenated fluoresceins against colistin-resistant gram-negative bacteriaPROVECTUS PHARMATECH INC·Filed 2024·Application pending·0 cites
- 2553US2025345275A1Micromolar Halogenated Fluorescein Assists in Full Skin-Thickness Wound HealingPROVECTUS PHARMATECH INC·Filed 2025·Application pending·0 cites
- 2651US12064507B2Composition and method for oral treatment of leukemiaPROVECTUS PHARMATECH INC·Filed 2021·Granted Aug 20, 2024·0 cites·27 claims
- 2750US2019030074A1Method of Ex Vivo Enhancement of Immune Cell Activity for Cancer Immunotherapy with a Small Molecule Ablative CompoundPROVECTUS PHARMATECH INC·Filed 2018·Application pending·0 cites
- 2848US2010076246A1Intracorporeal Medicaments for High Energy Phototherapeutic Treatment of DiseasePROVECTUS PHARMATECH INC·Filed 2009·Application pending·0 cites
- 2945US7384623B1High energy phototherapeutic agentsPROVECTUS PHARMATECH INC·Filed 1999·Granted Jun 10, 2008·8 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when PROVECTUS PHARMATECH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →